76310-024 NDC - FOSCAVIR ()

Drug Information

Product NDC: 76310-024
Proprietary Name: Foscavir
Non Proprietary Name:
Active Ingredient(s): 24 mg/mL FOSCARNET SODIUM24 mg/mL FOSCARNET SODIUM
Administration Route(s):
Dosage Form(s):
Pharmacy Class(es): Chelating Activity [MoA]; DNA Polymerase Inhibitors [MoA]; Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]; Pyrophosphate Analog [EXT]

Labeler Information

Field Name	Field Value
Labeler Name:	Clinigen Limited
Product Type:
FDA Application Number:	NDA020068
Marketing Category:	NDA
Start Marketing Date:	4/6/2021
End Marketing Date:	2/29/2024

Package Information

No.	Package Code	Package Description	Billing Unit
1	76310-024-01	10 CARTON in 1 CARTON (76310-024-01) / 1 BOTTLE in 1 CARTON (76310-024-11) / 250 mL in 1 BOTTLE	ML
2	76310-024-25	10 CARTON in 1 CARTON (76310-024-25) / 1 BOTTLE in 1 CARTON (76310-024-15) / 250 mL in 1 BOTTLE	ML
3	76310-024-45	10 POUCH in 1 CARTON (76310-024-45) / 1 BAG in 1 POUCH (76310-024-41) / 250 mL in 1 BAG	ML

NDC Record

Field Name	Field Value	Definition
PRODUCT NDC	76310-024	The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAME	Foscavir	The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE	4/6/2021	This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAME	NDA	Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBER	NDA020068	This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAME	Clinigen Limited	Name of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC	76310-024	The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAME	Foscavir	The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE	4/1/2014	This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAME	NDA	Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBER	NDA020068	This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAME	Clinigen Limited	Name of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC	76310-024	The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAME	Foscavir	The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE	7/9/2012	This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAME	NDA	Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBER	NDA020068	This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAME	Clinigen Limited	Name of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 4/25/2025

Previous Code

Next Code